Singapore to Host Inaugural Healthcare Travel Exhibition ...(EnterpriseSingapore International Medica...),Health
Navigation Links
Singapore to Host Inaugural Healthcare Travel Exhibition & Congress
Date:6/4/2009
Enterprise Singapore, International Medical Travel Association (IMTA), Life Insurance Association, Pacific Asia Travel Association (PATA), Spa and Wellness Association Singapore, Thai Spa Association, and Spa Association Singapore.
"Asia is right at the centre of the medical tourism phenomenon," said Andrew Keable, Divisional Director of Life Sciences Division, IIR Asia Pacific. "This makes Healthcare Travel Exhibition and Congress 2009 an excellent platform to discover opportunities and strike partnerships in Asia's thriving healthcare travel industry."
For more information, please visit http://www.healthcare-travel.com
About Informa Life Sciences
Healthcare Travel Exhibition & Congress is part of a global series of life sciences events organized by Informa Life Sciences, the world's leader in providing quality conferences, publications and learning experiences for the life sciences industry. Along with Arab Health, Hospital Build and Aesthetics Asia, Healthcare Travel Exhibition and Congress also takes place annually in Dubai.
Informa Life Sciences lead the market in providing quality, expert-led conferences; delivering the expert knowledge our clients need to excel in their professional roles and guaranteeing a competitive advantage for their organizations. Our diverse portfolio covers the Pharmaceutical (Drug Discovery, Clinical Development, Regulatory Affairs, Biopharmaceutical, Generics and Business Strategy), Medical Devices and Diagnostics, Fine Chemicals and Agrochemicals and Veterinary Medicine arenas.
For media enquiries, please contact:
Samuel Chua
Senior Communications Executive
Flame Communications
Tel: +65-6259-3193 / +65-6253-3193
Mobile: +65-9368-9821
Email: samuel@flamecomms.com
Yvonne Lim
'/>"/>
| SOURCE Informa Life Sciences Copyright©2009 PR Newswire. All rights reserved |
Related medicine news :
1. Lab-on-chip testing for bird flu developed by Singapore scientists
2. Hill-Rom Announces Singapore Will Be Site for Asia-Pacific Innovation Center
3. Three Hospitals in Singapore Join Companion Global Healthcare Network
4. Wyeth to Expand State-of-the-Art Nutritional Manufacturing Facility in Singapore
5. Hospital Care in Singapore Now Available to American Patients at Pre-Negotiated, In-Network Rates Far Lower than Comparable Services in the U.S.
6. Marian Koshland Science Museum forms partnership with Science Center Singapore
7. Jeffrey S. Williams Rejoins Alexza Pharmaceuticals as President, Alexza Singapore Pte. Ltd.
8. Singapore Is One of the Fastest Growing Bioclusters in Asia; Wave of Investments in Drug Discovery and Translational Research
9. Singapore Reinforces Position as a Global Site for Pharma & Biotech; Biomedical Manufacturing Output Quadruples to Reach US$17 Billion
10. Abaxis, Inc. CEO to Present at the Eighth Annual Forbes Global CEO Conference in Singapore
11. Singapore Medicine - First in South East Asia to Offer Robotic Surgery for Gynaecologic Cancers
Post Your Comments:
(Date:11/25/2009)...to overlook needed care, study finds , ,... depression can worsen her child,s asthma, U.S. re...f 262 black mothers and their children found that ...s had more frequent asthma symptoms, while childre...ss frequent asthma symptoms. , The Johns Hopkin...
(Date:11/25/2009)...ONSkincare ®isproudtosupportGNC,seffortstorai...t.Jude ThanksandGiving campaign,$1fromthepurchasep...Balm willbedonatedtoSt.Jude.Additionally,GNCcustom...eckoutatoneoftheir5,000+retaillocationsoratGNC.com...heir2009 ThanksandGiving campaign. ,, "Wearedel...
(Date:11/25/2009)...ried into the body on a carefully engineered, fing...eliminate tumors in mammals, scientists report thi...ine . , The new approach, pioneered by bioengine...plastic disks impregnated with tumor-specific anti... mammalian immune system to attack tumors. The new...
(Date:11/25/2009)...tumor cells, study finds , , WEDNESDAY, ...ered in a fingernail-size implant eliminated melan...method uses polymer disks, 8.5 millimeters in diam... and implanted under the skin to reprogram the imm...y scientists who developed the implant predicted t...
(Date:11/25/2009)...ds to include cost-effective, sustainable distance...rofessionals in developing world. , ...9 -- Elluminate, Inc. , the leader in web, audio...ort 21st century teaching, learning, and collabora...iative was awarded iNACOL,s first-ever Outstandin...
Breaking Medicine News(10 mins):Health News:Mom's Depression May Worsen Child's Asthma 2Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 2Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 3Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 4Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 5[0] Mom's Depression May Worsen Child's Asthma[2] MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R)[1] Implant-based cancer vaccine is first to eliminate tumors in mice[2] Implantable Cancer Vaccine Shows Promise[1] Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice
... BOSTON Since the days of Hippocrates, people hav...e seasons. More recently, researchers have learned...s seasonality, are often related to the weather. I...he Department of Public Heath and Family Medicine ...
...OS GATOS, Calif., Sept. 12 Death may be the last ...ked about. It is usually looked,upon as something ...but,Philip and Darlyne intend to tear down the wal...ng death and Philip,s loss. They have written this...
...Using all natural guacamole as a dip or condiment ... - September 16 , November 14)-, DALLAS, Sept. 12...inking -- avocados are great for you. (Photo: ht... -- and loaded with lutein which protects,against ...
...ONTREAL, Sept. 12 /PRNewswire/ - The Montreal-base... (ISIVF) will host the 14th World,Congress on In V...ess on,In-Vitro Maturation (IVM), at the Fairmont ...ogists in the field of,human fertility. "As IVF a...
...aiser Family Foundation: Premiums increased at slo...h insurance,premiums increased at the slowest pace...ar premium increases have declined, according to a...nnual Survey found,that health insurance premiums ...
...ACKSONVILLE, Fla., Sept. 11 In remarks presented ...,s (BCBSF) annual,policyholders, meeting, Chris Do...e Officer and Chief Financial Officer, reported th...(Logo: http://www.newscom.com/cgi-bin/prnh/200004...
Other Medicine News:Health News:Mathematics might save you a trip to the ER 2Health News:'Triumph' -- Traveling Towards Death: Preparing for a New Life 2Health News:Guacamole: Fights Hunger, Cholesterol and Cancer 2Health News:World fertility experts to meet in Montreal - IVF and IVM patients to provide first-person accounts at 14th World Congress 2Health News:Health Insurance Premium Growth Slows for Fourth Straight Year 2Health News:Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance 2Mathematics might save you a trip to the ER'Triumph' -- Traveling Towards Death: Preparing for a New LifeGuacamole: Fights Hunger, Cholesterol and CancerWorld fertility experts to meet in Montreal - IVF and IVM patients to provide first-person accounts at 14th World CongressHealth Insurance Premium Growth Slows for Fourth Straight YearBlue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
(Date:11/25/2009)...sia-FirstCall/--ChinaSkyOne,Medical,Inc.("ChinaSky...gfullyintegratedpharmaceuticalcompanydevelopingand...icofChina("PRC"),today,announcedthattheCompanyrece...lofPharmaceuticalandBiologicalProducts("ICPBP")exa...rHumanProstateSpecific,Antigen(ColloidalGold)andit...
(Date:11/25/2009)...--AccordingtoMillenniumResearchGroup(MRG),thegloba...enearly$3billionUSmarketfortraumafixationdeviceswi...itetherecenteconomicslowdown.MRG,s USMarketsforTra...inhighlydynamicoverthenextfiveyears,withcompetitor...vedsegmentsofthetraumafixationmarket,fuelingmarket...
(Date:11/25/2009)...URG,November25/PRNewswire/--,iThembaPharmaceutical...hattheyhavesignedacollaborativeagreementtojointlym...lasscomputationalchemistryandleaddiscoveryexpertis...demedicinaland,syntheticchemistrysupporttoprojects....iThembaPharmaceuticalsandPyxisDiscovery,alsoannou...
Breaking Medicine Technology:China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Worlds First Emergency Medical Device Franchise Launches eMed Alert 54194 1Worlds First Emergency Medical Device Franchise Launches eMed Alert 54194 2Worlds First Emergency Medical Device Franchise Launches eMed Alert 54194 3Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 4845 1Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 4845 2Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 4845 3Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 4845 4Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 4845 5Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 4845 6Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 4845 7Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 4845 8Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 4845 9Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 4845 10Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 4845 11TeamStaff Inc To Announce Third Quarter Results 54190 1TeamStaff Inc To Announce Third Quarter Results 54190 2TeamStaff Inc To Announce Third Quarter Results 54190 3[0] China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits[0] US Trauma Fixation Device Market Not Seeing Signs of Slowdown[0] iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering
...land, October 14 Arpida Ltd.,(SWX: ARPN) today an...Food,and Drug Administration (FDA) that the agency...scuss the New Drug Application (NDA) for,intraveno... Infections,(cSSSI) during its meeting on 18-20 No...d by FDA as part of the review process of an NDA o...
...SPIRIT II and SPIRIT III Data Confirms Patients Tr...cing Death, a Heart Attack or a Repeat P...NGTON, Oct. 13 Data from an independent,meta-anal...ed clinical,trials demonstrated that the XIENCE V(...nues to deliver clinically significant benefits fo...
Other Medicine Technology:Arpida Announces Review of Iclaprim NDA by FDA Advisory Committee in November 2008 2Arpida Announces Review of Iclaprim NDA by FDA Advisory Committee in November 2008 3Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 2Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 3Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 4Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 5Diamond Burr - Round
Pterygium Diamond Burr
Ruedemann Lacrimal Dilator
Wilder Lacrimal Dilator - Long
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |